Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Guzzo

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Urology|April 20, 2021
Preventing Prostate Biopsy Complications: to Augment or to Swab?Lydia Glick, Sage A Vincent, Danielle Squadron, et al.
Urology|September 7, 2021
EDITORIAL COMMENTLydia Glick, Sage A Vincent, Danielle Squadron, et al.
Urology|July 3, 2023
Longitudinal Changes in the Operative Experience for Junior Urology ResidentsEzra J Margolin, Daniel Schoenfeld, Caleb H Miles, et al.
Cancer Medicine|May 24, 2019
Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancerBenjamin W Fischer-Valuck, Jeff M Michalski, Nandita Mitra, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical CystectomyBrian C Baumann, Walter R Bosch, Amit Bahl, et al.
Urologic Oncology|December 13, 2023
Interruptions in bladder cancer care during the COVID-19 public health emergencyJohn L Gore, Kristin Follmer, Jason Reynolds, et al.
The Journal of Urology|May 5, 2024
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialVikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, et al.
The Lancet. Oncology|November 30, 2020
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trialStephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, et al.
European Urology|December 22, 2021
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical TrialAnirban P Mitra, Vikram M Narayan, Sharada Mokkapati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder CancerJohn L Gore, Erika M Wolff, Michael G Nash, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Urology|April 20, 2021
Preventing Prostate Biopsy Complications: to Augment or to Swab?Lydia Glick, Sage A Vincent, Danielle Squadron, et al.
Urology|September 7, 2021
EDITORIAL COMMENTLydia Glick, Sage A Vincent, Danielle Squadron, et al.
Urology|July 3, 2023
Longitudinal Changes in the Operative Experience for Junior Urology ResidentsEzra J Margolin, Daniel Schoenfeld, Caleb H Miles, et al.
Cancer Medicine|May 24, 2019
Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancerBenjamin W Fischer-Valuck, Jeff M Michalski, Nandita Mitra, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical CystectomyBrian C Baumann, Walter R Bosch, Amit Bahl, et al.
Urologic Oncology|December 13, 2023
Interruptions in bladder cancer care during the COVID-19 public health emergencyJohn L Gore, Kristin Follmer, Jason Reynolds, et al.
The Journal of Urology|May 5, 2024
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialVikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, et al.
The Lancet. Oncology|November 30, 2020
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trialStephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, et al.
European Urology|December 22, 2021
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical TrialAnirban P Mitra, Vikram M Narayan, Sharada Mokkapati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder CancerJohn L Gore, Erika M Wolff, Michael G Nash, et al.
Pageof 18